Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 11/20 | 0.60 |
| ▸ | CES1 | P23141 | 10/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108031 | 1.00 | CES2 (0.60) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL449946 | 1.00 | CES2 (0.60) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL28138711 | 1.00 | CES2 (0.60) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL11488533 | 0.88 | SMN1; SMN2 (0.59) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL11373661 | 0.88 | SMN1; SMN2 (0.59) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL11373666 | 0.88 | SMN1; SMN2 (0.59) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL11424490 | 0.85 | CES2 (0.54) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL11714645 | 0.83 | PARP10 (0.53) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL11714663 | 0.83 | PARP10 (0.53) | CES2CES1MAPTSMN1; SMN2POLB | |
| SCHEMBL28543716 | 0.82 | CES2 (0.50) | CES2CES1MAPTSMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114133467-B | Unsaturated esterified monomer and ester low-bleeding polycarboxylate superplasticizer and preparation method thereof | 科之杰新材料集团浙江有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-114133467-A | Unsaturated esterified monomer and ester low-bleeding polycarboxylate superplasticizer and preparation method thereof | 科之杰新材料集团浙江有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-109485806-B | Ester type super-slow-release polycarboxylic slump retaining agent and preparation method thereof | 科之杰新材料集团(广东)有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-109485806-A | A kind of super sustained-release polycarboxylic slump retaining agent of esters and preparation method thereof | 广东科之杰新材料有限公司 | 2019-03-19 | — | — | CN | claimed |
| US-20050020672-A1 | Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals | THE PROCTER & GAMBLE COMPANY | 2005-01-27 | — | — | US | claimed |
| EP-0754039-A4 | METHODS OF USING IRON CHELATING COMPOUNDS TO REDUCE FREE RADICAL DAMAGE IN MAMMALS | PROCTER & GAMBLE (US) | 2002-07-17 | — | — | EP | claimed |
| EP-1206241-A1 | METHODS OF LIGHTENING KERATINOUS TISSUE BY TOPICAL APPLICATION OF OXIME COMPOUND CONTAINING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-22 | — | — | EP | claimed |
| US-6287373-B1 | FOR ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-09-11 | — | — | US | claimed |
| WO-2001013882-A1 | METHODS OF LIGHTENING KERATINOUS TISSUE BY TOPICAL APPLICATION OF OXIME COMPOUND CONTAINING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-03-01 | — | — | WO | claimed |
| US-6187082-B1 | COMPOSITION COMPRISED OF THIOUREA AND INK CARBAMATE, EACH WITH SPECIFIED MELTING POINT AND ACOUSTIC-LOSS VALUE, LIGHTFASTNESS COMPONENT, LIGHTFAST ANTIOXIDANT, COLORANT | XEROX CORPORATION | 2001-02-13 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| CN-1145782-A | Method of using iron chelating compounds to reduce free radical damage in mammals | PROCTER & GAMBLE (US) | 1997-03-26 | — | — | CN | claimed |
| EP-0754039-A1 | METHODS OF USING IRON CHELATING COMPOUNDS TO REDUCE FREE RADICAL DAMAGE IN MAMMALS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-22 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| WO-1995027485-A1 | METHODS OF USING IRON CHELATING COMPOUNDS TO REDUCE FREE RADICAL DAMAGE IN MAMMALS | THE PROCTER & GAMBLE COMPANY (US) | 1995-10-19 | — | — | WO | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4583933-A1 | FLUOROPOLYMER MEDICAL DEVICES | Unomedical A/S (DK) | 2025-07-16 | — | — | EP | disclosed |
| EP-4583934-A1 | MEDICAL DEVICES | Unomedical A/S (DK) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024168218-A1 | WEARABLE ELECTROPHYSIOLOGICAL MONITORING SYSTEMS | THE UNIVERSITY OF MASSACHUSETTS (US) | 2024-08-15 | — | — | WO | disclosed |
| EP-4376912-A1 | INTERMITTENT CATHETERS | ConvaTec Limited (GB) | 2024-06-05 | — | — | EP | disclosed |
| EP-4376909-A1 | INTERMITTENT CATHETERS | ConvaTec Limited (GB) | 2024-06-05 | — | — | EP | disclosed |
| EP-4346935-A1 | COATING FOR MEDICAL DEVICES | Smart Reactors Service Limited (IE) | 2024-04-10 | — | — | EP | disclosed |
| WO-2024058031-A1 | ACTINIC-RAY-CURABLE RESIN COMPOSITION, CURED OBJECT, AND MULTILAYERED OBJECT | 荒川化学工業株式会社 | 2024-03-21 | — | — | WO | disclosed |
| WO-2024052192-A1 | FLUOROPOLYMER MEDICAL DEVICES | UNOMEDICAL A/S (DK) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052193-A1 | MEDICAL DEVICES | UNOMEDICAL A/S (DK) | 2024-03-14 | — | — | WO | disclosed |
| WO-2023234365-A1 | SOFT CONTACT LENS HAVING COATING LAYER | 日油株式会社 | 2023-12-07 | — | — | WO | disclosed |
| EP-4259822-A1 | SINGLE-BUFFER COMPOSITIONS FOR NUCLEIC ACID DETECTION | Mammoth Biosciences, Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| CN-116830039-A | Photosensitive resin composition, photosensitive resin sheet, cured product, hollow structure, electronic component, and elastic wave filter | 东丽株式会社 | 2023-09-29 | — | — | CN | disclosed |
| CN-116710391-A | Hollow structure, and electronic component and negative photosensitive resin composition using same | 东丽株式会社 | 2023-09-05 | — | — | CN | disclosed |
| CN-114730127-B | Photosensitive resin composition, photosensitive resin sheet, hollow structure, cured product, method for producing hollow structure, electronic component, and elastic wave filter | 东丽株式会社 | 2023-05-12 | — | — | CN | disclosed |
| US-20230135772-A1 | CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-114133467-B | Unsaturated esterified monomer and ester low-bleeding polycarboxylate superplasticizer and preparation method thereof | 科之杰新材料集团浙江有限公司 | 2023-04-18 | — | — | CN | disclosed |
| EP-4130154-A1 | CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT | Asahi Kasei Kabushiki Kaisha (JP) | 2023-02-08 | — | — | EP | disclosed |
| WO-2023007131-A1 | INTERMITTENT CATHETERS | CONVATEC LIMITED (GB) | 2023-02-02 | — | — | WO | disclosed |
| WO-2023007128-A1 | INTERMITTENT CATHETERS | CONVATEC LIMITED (GB) | 2023-02-02 | — | — | WO | disclosed |
| WO-2022271873-A2 | PROGRAMMABLE NUCLEASE DIAGNOSTIC DEVICE | MAMMOTH BIOSCIENCES, INC. (US) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022253780-A1 | COATING FOR MEDICAL DEVICES | Smart Reactors Service Limited (IE) | 2022-12-08 | — | — | WO | disclosed |
| WO-2022241032-A1 | ENHANCED GUIDE NUCLEIC ACIDS AND METHODS OF USE | MAMMOTH BIOSCIENCES, INC. (US) | 2022-11-17 | — | — | WO | disclosed |
| CN-115190901-A | Carbodiimide composition, curing agent composition, coating composition, and resin cured product | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022132833-A1 | SINGLE-BUFFER COMPOSITIONS FOR NUCLEIC ACID DETECTION | MAMMOTH BIOSCIENCES, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| CN-114133467-A | Unsaturated esterified monomer and ester low-bleeding polycarboxylate superplasticizer and preparation method thereof | 科之杰新材料集团浙江有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-109485806-B | Ester type super-slow-release polycarboxylic slump retaining agent and preparation method thereof | 科之杰新材料集团(广东)有限公司 | 2021-02-26 | — | — | CN | disclosed |
| WO-2020129087-A1 | NOVEL PROCESS FOR THE PREPARATION OF R-PHENYLACETYLCARBINOL AND β-AMINOALCOHOLS | MALLADI DRUGS AND PHARMACEUTICALS LTD. (IN) | 2020-06-25 | — | — | WO | disclosed |
| CN-109485806-A | A kind of super sustained-release polycarboxylic slump retaining agent of esters and preparation method thereof | 广东科之杰新材料有限公司 | 2019-03-19 | — | — | CN | disclosed |
| CN-105951307-A | High-performance anti-radiation metal fabric and preparation method thereof | 苏州洪河金属制品有限公司 | 2016-09-21 | — | — | CN | disclosed |
| EP-2753604-B1 | PDE10 MODULATORS | HOFFMANN LA ROCHE (CH) | 2015-08-19 | — | — | EP | disclosed |
| US-8772510-B2 | PDE10 modulators | HOFFMANN-LA ROCHE INC. (US) | 2014-07-08 | — | — | US | disclosed |
| WO-2013034506-A1 | PDE10 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2013-03-14 | — | — | WO | disclosed |
| US-20130059833-A1 | PDE10 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2013-03-07 | — | — | US | disclosed |
| EP-1599454-B1 | DIARYLCYCLOALKYL DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2012-12-26 | — | — | EP | disclosed |
| US-8318796-B2 | Heterocyclic compounds and thrombopoietin receptor activators | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20110077290-A1 | HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | NISSAN CHEMICAL INDUSTRIES LIMITED (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110064662-A1 | KIT FOR PRODUCING MOLECULAR PROBE FOR PET SCREENING FOR DRUG DISCOVERY | RIKEN (JP) | 2011-03-17 | — | — | US | disclosed |
| US-7872034-B2 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| US-7872034-B2 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| US-7872034-B2 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| EP-2228363-A1 | KIT FOR USE IN PRODUCTION OF MOLECULAR PROBE FOR PET DRUG SCREENING | Riken (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-7615321-B2 | Color filter | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-11-10 | — | — | US | disclosed |
| EP-1756096-B1 | INDOLYL DERIVATIVES AS LIVER-X-RECEPTOR MODULATORS | HOFFMANN LA ROCHE (CH) | 2009-08-12 | — | — | EP | disclosed |
| EP-1599455-B1 | 4-(3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXYLOXY)-BUTANE ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR TREATING DIABETES OF TYPE 2 AND ATHEROSCLEROSIS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-07-01 | — | — | EP | disclosed |
| EP-1599455-B1 | 4-(3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXYLOXY)-BUTANE ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR TREATING DIABETES OF TYPE 2 AND ATHEROSCLEROSIS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-07-01 | — | — | EP | disclosed |
| EP-1735266-B1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE 1-ERYTHRO-2-AMINO-1-PHENYL-1-PROPANOL | EMMELLEN BIOTECH PHARMACEUTICA (IN) | 2009-06-24 | — | — | EP | disclosed |
| EP-1599453-B1 | 3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINO BUTYRIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATHEROSCLEROSIS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-05-06 | — | — | EP | disclosed |
| EP-1599453-B1 | 3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINO BUTYRIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATHEROSCLEROSIS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-05-06 | — | — | EP | disclosed |
| US-7485652-B2 | Indolyl derivatives as liver-X-receptor (LXR) modulators | HOFFMANN-LA ROCHE INC. (US) | 2009-02-03 | — | — | US | disclosed |
| US-7470713-B2 | Imidazole based kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470713-B2 | Imidazole based kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470713-B2 | Imidazole based kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-30 | — | — | US | disclosed |
| CN-100439345-C | (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. | SANNOFFE AVENTIS PHARMA GMBH (DE) | 2008-12-03 | — | — | CN | disclosed |
| US-20080286666-A1 | COLOR FILTER AND METHOD OF PRODUCING SAME | KOBAYASHI HIRONORI | 2008-11-20 | — | — | US | disclosed |
| US-7414153-B2 | Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanol | EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (IN) | 2008-08-19 | — | — | US | disclosed |
| US-7414153-B2 | Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanol | EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (IN) | 2008-08-19 | — | — | US | disclosed |
| US-20080167354-A1 | ARYLYCLOALKYL-SUBSTITUTED ALKANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080167354-A1 | ARYLYCLOALKYL-SUBSTITUTED ALKANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080167354-A1 | ARYLYCLOALKYL-SUBSTITUTED ALKANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| CN-100398526-C | 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-07-02 | — | — | CN | disclosed |
| US-7365084-B2 | Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-04-29 | — | — | US | disclosed |
| US-7365084-B2 | Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-04-29 | — | — | US | disclosed |
| US-7365084-B2 | Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-04-29 | — | — | US | disclosed |
| US-7335671-B2 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7335671-B2 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7335671-B2 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-02-26 | — | — | US | disclosed |
| US-20080015238-A1 | CYCLOALKYLMETHOXY-SUBSTITUTED ACETIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-01-17 | — | — | US | disclosed |
| US-20080015238-A1 | CYCLOALKYLMETHOXY-SUBSTITUTED ACETIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-01-17 | — | — | US | disclosed |
| US-20080015238-A1 | CYCLOALKYLMETHOXY-SUBSTITUTED ACETIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-01-17 | — | — | US | disclosed |
| US-20070203363-A1 | Process For Preparation Of Optically Active 1-Erythro-2-Amino-1-Phenyl-1-Propanol | EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (IN) | 2007-08-30 | — | — | US | disclosed |
| US-20070203363-A1 | Process For Preparation Of Optically Active 1-Erythro-2-Amino-1-Phenyl-1-Propanol | EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (IN) | 2007-08-30 | — | — | US | disclosed |
| US-7259177-B2 | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| US-7259177-B2 | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| US-7259177-B2 | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| US-20070146914-A1 | Color filter | DAI NIPPON PRINTING CO., LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1599452-B1 | 3-(2-PHENYL-OXAZOL-4-YL METHOXY) CYCLOHEXYLMETHOXY ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS USED AS PPAR MODULATORS FOR TREATING TYPE 2 DIABETES AND ARTERIOSCLEROSIS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-06-20 | — | — | EP | disclosed |
| EP-1599452-B1 | 3-(2-PHENYL-OXAZOL-4-YL METHOXY) CYCLOHEXYLMETHOXY ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS USED AS PPAR MODULATORS FOR TREATING TYPE 2 DIABETES AND ARTERIOSCLEROSIS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-06-20 | — | — | EP | disclosed |
| US-20070099916-A1 | Indolyl derivatives as liver-x-receptor (LXR) modulators | DEHMLOW HENRIETTA | 2007-05-03 | — | — | US | disclosed |
| CN-1950365-A | Indolyl derivatives as liver-X-receptor modulators | HOFFMANN LA ROCHE (CH) | 2007-04-18 | — | — | CN | disclosed |
| EP-1756096-A1 | INDOLYL DERIVATIVES AS LIVER-X-RECEPTOR MODULATORS | F.HOFFMANN-LA ROCHE AG (CH) | 2007-02-28 | — | — | EP | disclosed |
| US-7173048-B2 | Indolyl derivatives as liver-X-receptor (LXR) modulators | HOFFMANN-LA ROCHE INC. (US) | 2007-02-06 | — | — | US | disclosed |
| US-20060222970-A1 | Color filter and method of producing same | DAI NIPPON PRINTING CO., LTD. | 2006-10-05 | — | — | US | disclosed |
| CN-1756748-A | 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-04-05 | — | — | CN | disclosed |
| CN-1753879-A | 3- (2-phenyl-oxazol-4-ylmethoxy) cyclohexyl methoxyacetic acid derivatives and related compounds as PPAR modulators for the treatment of type 2 diabetes and atherosclerosis | SANNOFFE AVENTIS PHARMA GMBH (DE) | 2006-03-29 | — | — | CN | disclosed |
| US-20060054290-A1 | Novel catalytic activities of oxidoreductases for oxidation and or bleaching | CALL HANS-PETER | 2006-03-16 | — | — | US | disclosed |
| EP-1599453-A1 | 3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINO BUTYRIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATHEROSCLEROSIS | Sanofi-Aventis Deutschland GmbH (DE) | 2005-11-30 | — | — | EP | disclosed |
| EP-1599454-A2 | DIARYLCYCLOALKYL DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | Sanofi-Aventis Deutschland GmbH (DE) | 2005-11-30 | — | — | EP | disclosed |
| EP-1599455-A1 | 4-(3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXYLOXY)-BUTANE ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR TREATING DIABETES OF TYPE 2 AND ATHEROSCLEROSIS | Sanofi-Aventis Deutschland GmbH (DE) | 2005-11-30 | — | — | EP | disclosed |
| EP-1599452-A1 | 3-(2-PHENYL-OXAZOL-4-YL METHOXY) CYCLOHEXYLMETHOXY ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS USED AS PPAR MODULATORS FOR TREATING TYPE 2 DIABETES AND ARTERIOSCLEROSIS | Sanofi-Aventis Deutschland GmbH (DE) | 2005-11-30 | — | — | EP | disclosed |
| WO-2005105791-A1 | INDOLYL DERIVATIVES AS LIVER-X-RECEPTOR MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-10 | — | — | WO | disclosed |
| US-20050245515-A1 | Indolyl derivatives as liver-X-receptor (LXR) modulators | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-03 | — | — | US | disclosed |
| US-20050215596-A1 | Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-09-29 | — | — | US | disclosed |
| WO-2005082885-A1 | IMIDAZOLE BASED KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-09-09 | — | — | WO | disclosed |
| US-20050187218-A1 | Imidazole based kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2005-08-25 | — | — | US | disclosed |
| US-20050147766-A1 | Process for manufacturing pattern forming body | AOKI DAIGO (JP) | 2005-07-07 | — | — | US | disclosed |
| US-20050101637-A1 | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-05-12 | — | — | US | disclosed |
| US-20050020672-A1 | Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals | THE PROCTER & GAMBLE COMPANY | 2005-01-27 | — | — | US | disclosed |
| US-20050020672-A1 | Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals | THE PROCTER & GAMBLE COMPANY | 2005-01-27 | — | — | US | disclosed |
| US-20040209920-A1 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-10-21 | — | — | US | disclosed |
| WO-2004076427-A1 | 3-(2-PHENYL-OXAZOL-4-YL METHOXY) CYCLOHEXYLMETHOXY ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS USED AS PPAR MODULATORS FOR TREATING TYPE 2 DIABETES AND ARTERIOSCLEROSIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-09-10 | — | — | WO | disclosed |
| WO-2004076426-A1 | 3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINO BUTYRIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATHEROSCLEROSIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-09-10 | — | — | WO | disclosed |
| WO-2004076428-A1 | 4-(3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXYLOXY)-BUTANE ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR TREATING DIABETES OF TYPE 2 AND ATHEROSCLEROSIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-09-10 | — | — | WO | disclosed |
| WO-2004075815-A2 | DIARYLCYCLOALKYL DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-09-10 | — | — | WO | disclosed |
| EP-1436371-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | Call, Krimhild (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-20030129321-A1 | Process for manufacturing pattern forming body | DAI NIPPON PRINTING CO., LTD. (JP) | 2003-07-10 | — | — | US | disclosed |
| US-20030018165-A1 | Uses of suppressive macrophage activation factors | INNOGENETICS N.V. (BE) | 2003-01-23 | — | — | US | disclosed |
| WO-2002099023-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | CALL, KRIMHILD (DE) | 2002-12-12 | — | — | WO | disclosed |
| EP-1233779-A2 | NEW USES OF SUPPRESSIVE MACROPHAGE ACTIVATION FACTORS | INNOGENETICS N.V. (BE) | 2002-08-28 | — | — | EP | disclosed |
| EP-0754039-A4 | METHODS OF USING IRON CHELATING COMPOUNDS TO REDUCE FREE RADICAL DAMAGE IN MAMMALS | PROCTER & GAMBLE (US) | 2002-07-17 | — | — | EP | disclosed |
| US-6328943-B1 | CONTACTING IRON SULFIDES AND/OR PRECURSORS THEREOF IN THE PRESENCE OF AIR WITH AN EFFECTIVE INHIBITING AMOUNT OF A TREATMENT COMPOUND SELECTED FROM AMINE, ALCOHOL, KETONE, OR MIXTURES | BETZDEARBORN INC. | 2001-12-11 | — | — | US | disclosed |
| US-6287373-B1 | FOR ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-09-11 | — | — | US | disclosed |
| WO-2001039786-A2 | NEW USES OF SUPPRESSIVE MACROPHAGE ACTIVATION FACTORS | INNOGENETICS N.V. (BE) | 2001-06-07 | — | — | WO | disclosed |
| EP-0820435-B1 | METHOD OF PREPARING ESSENTIALLY PURE ISOMERS OF ALPHA-BIS-OXIMES | BASF AG (DE) | 2001-05-16 | — | — | EP | disclosed |
| US-6187082-B1 | COMPOSITION COMPRISED OF THIOUREA AND INK CARBAMATE, EACH WITH SPECIFIED MELTING POINT AND ACOUSTIC-LOSS VALUE, LIGHTFASTNESS COMPONENT, LIGHTFAST ANTIOXIDANT, COLORANT | XEROX CORPORATION | 2001-02-13 | — | — | US | disclosed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | disclosed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | disclosed |
| EP-1012376-A2 | OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS | Blume, Hildegard (DE) | 2000-06-28 | — | — | EP | disclosed |
| EP-0873307-B1 | CYANIMINO OXIME ETHERS, PROCESS AND INTERMEDIATES FOR THE PREPARATION AND USE THEREOF FOR THE CONTROL OF NOXIOUS FUNGI AND ANIMAL PESTS | BASF AG (DE) | 2000-05-31 | — | — | EP | disclosed |
| US-6063813-A | FUNGICIDES AND INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-16 | — | — | US | disclosed |
| US-6045607-A | FIRST AND SECOND SOLID CARBAMATES WITH A DISSIMILAR MELTING POINTS; LIGHTFASTNESS COMPONENT; A LIGHTFASTNESS ANTIOXIDANTS, AND A COLORANT; USEFUL FOR ACOUSTIC INK PRINTING | XEROX CORPORATION (US) | 2000-04-04 | — | — | US | disclosed |
| US-5929279-A | Preparation of Bisoximes | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-27 | — | — | US | disclosed |
| US-5922758-A | REDUCING OR PREVENTING OZONE, SMOKE AND/OR POLLUTION DAMAGE TO MAMMALIAN SKIN BY APPLYING A MAMMALIAN SKIN AN EFFECTIVE AMOUNT OF COMPOUND SELECTED FROM 2,4-DIENOIC ACID ESTER OF TOCOPHEROLS, SUCH AS ALPHA, BETA, ZETA1, ZETA2 AND OTHERS | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-13 | — | — | US | disclosed |
| WO-1998059108-A2 | OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS | BLUME, HILDEGARD (DE) | 1998-12-30 | — | — | WO | disclosed |
| US-5739156-A | ADMINISTERING TO REDUCE NONULTRAVIOLET-INDUCED FREE RADICAL DAMAGE OR AGING | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-14 | — | — | US | disclosed |
| EP-0820435-A1 | METHOD OF PREPARING ESSENTIALLY PURE ISOMERS OF $g(a)-BIS-OXIMES | BASF AKTIENGESELLSCHAFT (DE) | 1998-01-28 | — | — | EP | disclosed |
| CN-1145782-A | Method of using iron chelating compounds to reduce free radical damage in mammals | PROCTER & GAMBLE (US) | 1997-03-26 | — | — | CN | disclosed |
| CN-1145782-A | Method of using iron chelating compounds to reduce free radical damage in mammals | PROCTER & GAMBLE (US) | 1997-03-26 | — | — | CN | disclosed |
| EP-0754039-A1 | METHODS OF USING IRON CHELATING COMPOUNDS TO REDUCE FREE RADICAL DAMAGE IN MAMMALS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-22 | — | — | EP | disclosed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | disclosed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | disclosed |
| WO-1996032373-A1 | METHOD OF PREPARING ESSENTIALLY PURE ISOMERS OF α-BIS-OXIMES | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-17 | — | — | WO | disclosed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | disclosed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | disclosed |
| WO-1995027485-A1 | METHODS OF USING IRON CHELATING COMPOUNDS TO REDUCE FREE RADICAL DAMAGE IN MAMMALS | THE PROCTER & GAMBLE COMPANY (US) | 1995-10-19 | — | — | WO | disclosed |
| US-5364617-A | Protection from solar radiation, chelate with iron in body and reduce its ability to catalyze formation of oxygen free radicals | THE PROCTER & GAMBLE COMPANY (US) | 1994-11-15 | — | — | US | disclosed |
| US-4818770-A | APPLYING ALPHA-DIFLUOROMETHYL-ORNITHINE INHIBITOR | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH (US) | 1989-04-04 | — | — | US | disclosed |
| WO-1988002986-A1 | PREVENTION OF A PLANT DISEASE BY SPECIFIC INHIBITION OF FUNGAL POLYAMINE BIOSYNTHESIS | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH (US) | 1988-05-05 | — | — | WO | disclosed |
| EP-0129381-B1 | RECORD MATERIAL | The Wiggins Teape Group Limited (GB) | 1987-08-12 | — | — | EP | disclosed |
| EP-0097124-B1 | PROCESS FOR THE PHOTOPOLYMERISATION OF UNSATURATED COMPOUNDS | CIBA-GEIGY AG (CH) | 1986-10-15 | — | — | EP | disclosed |
| US-4574294-A | Record material | THE WIGGINS TEAPE GROUP LIMITED (GB) | 1986-03-04 | — | — | US | disclosed |
| US-4567498-A | CONTAINING CATIONIC SOFTENING AGENT | THE WIGGINS TEAPE GROUP LIMITED (GB) | 1986-01-28 | — | — | US | disclosed |
| US-4498964-A | PHOTOINITIATORS FOR HIGH-SPEED CURING OF PRINTING INKS, PAINTS, PHOTORESISTS AND FILMS | CIBA-GEIGY CORPORATION (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0129381-A1 | Record material | The Wiggins Teape Group Limited (GB) | 1984-12-27 | — | — | EP | disclosed |
| EP-0129380-A1 | Record material | The Wiggins Teape Group Limited (GB) | 1984-12-27 | — | — | EP | disclosed |
| EP-0097124-A2 | Process for the photopolymerisation of unsaturated compounds | CIBA-GEIGY AG (CH) | 1983-12-28 | — | — | EP | disclosed |
| EP-0000082-B1 | PROCESS FOR IMAGE-WISE MODIFYING THE SURFACE OF AN ETCHABLE SUPPORT AND MATERIAL SUITABLE THEREFOR COMPRISING A COLLOID LAYER CONTAINING POLYMERS WITH OXIME-ESTER GROUPS | AGFA-GEVAERT N.V. (BE) | 1982-07-21 | — | — | EP | disclosed |
| EP-0014344-B1 | COUMARIN COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS WHITENERS AND LASER DYES | BAYER AG (DE) | 1982-04-21 | — | — | EP | disclosed |
| US-4326066-A | Triazolyl coumarin compounds, processes for their preparation and their use as whiteners and laser dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-20 | — | — | US | disclosed |
| US-4293552-A | Novel 1-(mono-o-substituted benzoyl)-3-(substituted pyrazinyl) ureas | ELI LILLY AND COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| EP-0014344-A1 | Coumarin compounds, process for their preparation and their use as whiteners and laser dyes | BAYER AG (DE) | 1980-08-20 | — | — | EP | disclosed |
| US-4202697-A | Production of etch-resist colloid and material suitable therefor | AGFA-GEVAERT N.V. (BE) | 1980-05-13 | — | — | US | disclosed |
| US-4160834-A | INSECTICIDES | ELI LILLY AND COMPANY (US) | 1979-07-10 | — | — | US | disclosed |
| EP-0000082-A1 | Process for image-wise modifying the surface of an etchable support and material suitable therefor comprising a colloid layer containing polymers with oxime-ester groups | AGFA-GEVAERT N.V. (BE) | 1978-12-20 | — | — | EP | disclosed |
| US-4083977-A | Novel insecticidal 1-(substituted benzoyl)-3-(substituted pyrazinyl)ureas | ELI LILLY AND COMPANY (US) | 1978-04-11 | — | — | US | disclosed |
| US-4083977-A | Novel insecticidal 1-(substituted benzoyl)-3-(substituted pyrazinyl)ureas | ELI LILLY AND COMPANY (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167354-A1 | ARYLYCLOALKYL-SUBSTITUTED ALKANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | GPR119, FFAR1, FFAR2 | CES2 404/4885CES1 109/4885MAPT 4175/4885 |
| US-20110077290-A1 | HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | NR2C2, ROR1, NR0B2 | CES2 3384/4885CES1 3557/4885MAPT 3117/4885 |
| US-20050245515-A1 | Indolyl derivatives as liver-X-receptor (LXR) modulators | INSR, NR1H2, NR1H3 | CES2 1726/4885CES1 56/4885MAPT 3167/4885 |
| US-20050215596-A1 | Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals | DNPEP, DDC, AADAT | CES2 325/4885CES1 1582/4885MAPT 914/4885 |
| US-20030018165-A1 | Uses of suppressive macrophage activation factors | ILF3, ILF2, MIF | CES2 4790/4885CES1 3879/4885MAPT 4724/4885 |
| US-20080015238-A1 | CYCLOALKYLMETHOXY-SUBSTITUTED ACETIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | GPR119, PC, ACADM | CES2 266/4885CES1 78/4885MAPT 3874/4885 |
| US-20050020672-A1 | Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals | TXNRD2, PRDX5, PLPBP | CES2 4233/4885CES1 3291/4885MAPT 4534/4885 |
| US-20070203363-A1 | Process For Preparation Of Optically Active 1-Erythro-2-Amino-1-Phenyl-1-Propanol | HMOX1, HMOX2, OXER1 | CES2 4524/4885CES1 3220/4885MAPT 2919/4885 |
| US-20070099916-A1 | Indolyl derivatives as liver-x-receptor (LXR) modulators | INSR, NR1H2, NR1H3 | CES2 1726/4885CES1 56/4885MAPT 3167/4885 |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | CES2 538/4885CES1 1449/4885MAPT 486/4885 |
| US-20130059833-A1 | PDE10 MODULATORS | PDE10A, PDE5A, PDE2A | CES2 479/4885CES1 200/4885MAPT 1196/4885 |
| US-20040209920-A1 | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | GPR119, FFAR1, FFAR2 | CES2 362/4885CES1 47/4885MAPT 4342/4885 |
| US-20050187218-A1 | Imidazole based kinase inhibitors | MAP3K19, MAP3K1, ABL1 | CES2 4498/4885CES1 3373/4885MAPT 2267/4885 |
| US-20110064662-A1 | KIT FOR PRODUCING MOLECULAR PROBE FOR PET SCREENING FOR DRUG DISCOVERY | KIT, TPX2, RUNX1 | CES2 465/4885CES1 2322/4885MAPT 3061/4885 |
| US-20050101637-A1 | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals | GPR119, PC, CPT1A | CES2 213/4885CES1 83/4885MAPT 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.